Interaction of olanzapine with fluvoxamine

被引：15

作者：

de Jong, J ^{[1
]}

Hoogenboom, B ^{[1
]}

van Troostwijk, LD ^{[1
]}

de Haan, L ^{[1
]}

机构：

[1] Univ Amsterdam, Acad Med Ctr, Dept Psychiat A3 260, NL-1100 DE Amsterdam, Netherlands

来源：

PSYCHOPHARMACOLOGY | 2001年 / 155卷 / 02期

关键词：

D O I：

10.1007/s002130100713

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：219 / 220

页数：2

共 12 条

[1] Olanzapine - Pharmacokinetic and pharmacodynamic profile [J].

Callaghan, JT ;

Bergstrom, RF ;

Ptak, LR ;

Beasley, CM .

CLINICAL PHARMACOKINETICS, 1999, 37 (03) :177-193

[2] Subjective experience and striatal dopamine D2 receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone [J].

de Haan, L ;

Lavalaye, J ;

Linszen, D ;

Dingemans, PMAJ ;

Booij, J .

AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (06) :1019-1020

[3]

Ereshefsky L, 1996, J CLIN PSYCHIAT, V57, P12

[4]

FARDE L, 1992, ARCH GEN PSYCHIAT, V49, P538

[5] THE USE OF CAFFEINE FOR ENZYME ASSAYS - A CRITICAL-APPRAISAL [J].

KALOW, W ;

TANG, BK .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (05) :503-514

[6]

Kapur S, 1999, AM J PSYCHIAT, V156, P286

[7]

KOCH JP, 1998, ZIEKENHUISFARMACIE, V14, P159

[8] Selective serotonin reuptake inhibitor-induced mydriasis [J].

Larson, M ;

Folstein, S .

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2000, 39 (02) :138-139

[9]

Maenpaa J., 1997, Clinical Pharmacology and Therapeutics, V61, P225

[10] A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables [J].

Naber, D .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 10 :133-138

← 1 2 →